老虎证券

BUZZ-Windtree Therapeutics rises on licensing deal for birth control vaginal gel

Reuters
2025/03/21
BUZZ-Windtree <a href="https://laohu8.com/S/LENZ">Therapeutics</a> rises on licensing deal for birth control vaginal gel

** Shares of biotechnology firm Windtree Therapeutics WINT.O rise 27.8% to $2.16 in afternoon trading

** WINT says it has entered into a licensing deal with Evofem Biosciences EVFM.PK for its birth control vaginal gel, Phexxi

** WINT will serve as the sourcing partner to Evofem and aims to produce Phexxi at a cheaper cost

** Co says Evofem will maintain ownership of the asset and continue to commercialize Phexxi in the U.S. and internationally

** Up to last close, WINT has fallen 99.4% in the past 12 months

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10